For over ten years, Eviti Connect has empowered oncology practices and health plans to prescribe and reimburse high-quality, high-value patient care....
We are excited about the recent launch of Eviti Connect® for autoimmune diseases, aimed at helping payers and providers realize...
As oncology costs continue to escalate and treatment decisions are more complex than ever, Eviti Connect empowers providers and payers...
Many factors go into making an informed treatment decision. Eviti Advisor supports physicians in the treatment decision process using a...
The cost of oncology-focused drugs in the U.S. has now exceeded $56 billion and the median annual expense of a new cancer...
There is no doubt that COVID-19 has had a tremendous impact on the U.S. healthcare system, forcing everyone—from payers to...
Approximately 60 percent of U.S. companies are partially or fully self-funding their health plans. With more than a third of...
For payers, Eviti Connect streamlines the authorization of cancer treatment, ensuring prescription of high-quality, high-value care and setting patients on...
In the final installment of our four-part webinar on “The Evolution of Value-Based Care: A Shift to Patient-Centric Care,” we...
In part three of this four-part series from our webinar “The Evolution of Value-Based Care: A Shift to Patient-Centric Care,”...
In part two of this four-part series from our webinar “The Evolution of Value-Based Care: A Shift to Patient-Centric Care,”...
In 2018, spending on cancer drugs in the United States has more than doubled since 2013 and has now exceeded...
